Overview
The fund is passively managed and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
MSCI UK Selection (NR) in GBP Index consists of large and mid cap companies in the UK markets that provides exposure to companies with high Environmental, Social and Governance (ESG) performance relative to their sector peers and captures large and mid-cap companies in UK.
The fund will not enter into any securities lending.
Benefits
Provides access to the performance of the index with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
The fund offers a high degree of transparency and cost efficiency.
UCITS compliant fund.
Risks
Features
| Product category |
UBS Equity Funds UBS Index Funds Equities |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
State Street Bank International GmbH, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS AG, Stockholm
|
| Day of inception |
October 29, 2020
|
| Currency of account |
GBP
|
| Close of financial year |
December 31
|
| SFDR Classification |
Art.8
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.20% p.a.
|
| Total expense ratio (TER) |
0.16% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI UK Selection (NR) in GBP
|
| Distribution Frequency |
n.a.
|
| ISIN |
LU2189789758
|
| Bloomberg Ticker |
CSEBQBG LX
|
| Reuters Id |
55299554X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| GBP(%) | EUR(%) | |
| YTD | ||
| 1M | ||
| 3M | ||
| 6M | ||
| 1Y | 24.48 | 22.80 |
| 2Y | ||
| 3Y | 42.14 | 45.13 |
| 5Y | 66.23 | 66.98 |
| ø p.a.5Y | 10.70 | 10.80 |
Current data
| Net asset value | 23.04.2026 | GBP 1,966.94 |
| High - last 12 months | 27.02.2026 | GBP 2,084.59 |
| Low - last 12 months | 25.04.2025 | GBP 1,578.03 |
| Assets of the unit class in mn | 23.04.2026 | GBP 16.03 |
| Total product assets in mn | 23.04.2026 | GBP 61.53 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| AstraZeneca PLC | 20.51 |
| HSBC Holdings PLC | 18.89 |
| Unilever PLC | 8.24 |
| National Grid PLC | 5.68 |
| Lloyds Banking Group PLC | 4.89 |
| RELX PLC | 4.06 |
| Anglo American Plc | 3.20 |
| Reckitt Benckiser Group PLC | 2.95 |
| SSE PLC | 2.82 |
| Tesco PLC | 2.72 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
||
| Prospectus |
|
||
| Key Information Document |
|
|
|
| Past performance |
|
|
|
| Previous performance scenario |
|
|
|
| Statutes / Management regulations |
|
|
Document type
|
Document Language
|
| Annual report |
|
| Semi-annual report |
|